Posted by Michael Wonder on 29 Dec 2018
Medicine for the treatment of seizures listed on the PBS
29 December 2018 - The Liberal National Government will make a medicine for the treatment of seizures associated with tuberous sclerosis more affordable, saving patients $17,000 a year.
The medicine Afinitor (everolimus) is being listed on the expert Pharmaceutical Benefits Scheme (PBS) from January 1, for the treatment of refractory seizures associated with tuberous sclerosis complex.
The medicine would cost around $17,000 per patient, per year without PBS subsidy. Under the PBS the price goes down to just $40.30 per script, or $6.50 for concessional patients.
